HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Complement 3b Receptors

Molecular sites on or in some B-lymphocytes and macrophages that recognize and combine with COMPLEMENT C3B. The primary structure of these receptors reveal that they contain transmembrane and cytoplasmic domains, with their extracellular portion composed entirely of thirty short consensus repeats each having 60 to 70 amino acids.
Also Known As:
Receptors, Complement 3b; CD 35 Antigens; CD35 Antigen; Complement 3b Receptor; Antigen, CD35; Antigens, CD 35; Receptor, Complement 3b; Antigens, CD35; C3b Receptors; CD35 Antigens; CR1 Receptors; Receptors, C3b; Receptors, CR1
Networked: 53 relevant articles (2 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Hewitt, Finnegan B: 1 article (02/2015)
2. Holers, V Michael: 1 article (02/2015)
3. Kulik, Liudmila: 1 article (02/2015)
4. Rodriguez, Rosa: 1 article (02/2015)
5. Tomlinson, Stephen: 1 article (02/2015)
6. Willis, Van C: 1 article (02/2015)
7. Bergseth, Grethe: 1 article (09/2011)
8. Brandtzaeg, Petter: 1 article (09/2011)
9. Brekke, Ole-Lars: 1 article (09/2011)
10. Castellheim, Albert: 1 article (09/2011)

Related Diseases

1. Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
2. Glomerulonephritis
3. Neoplasms (Cancer)
10/01/1982 - "Studies of the C3b and C3b' receptors of these monocytes showed that the function of both receptors could be dramatically altered by treating the cells with tumor-promoting phorbol esters. "
10/20/2001 - "The detection of red-cell immune funtions included the rossett rate of red-cell immune adherence activity of C3b receptors ( RBC-C3bRR) and that of red-cell immune complex ( RBC-ICR) and that of direct erythrocyte-cancer cell immune adherence ( RBC-CaR) . "
02/01/1997 - "FZF herbs could increase the activity of red blood cell C3b receptors, reduce the quantity of red blood cell immune complexes, elevate the immune adherent function of red blood cells to tumor cells, raise activity of red blood cell immune adherent enhancing factors in serum, and lower the activity of red blood cell immune adherent inhibitory factors. "
02/01/1997 - "Chemotherapy could reduce the activity of red blood cell C3b receptors, increase the quantity of red blood cell immune complexes, depress the immune adherent function of red blood cells to tumor cells, lower the activity of red blood cell immune adherent enhancing factors in serum, and raise the activity of red blood cell immune adherent inhibitory factors in serum. "
06/01/2007 - "Treatment with ZYD88 in adult C57BL/6 mice with metastatic LLC produced dose-dependent deceases in primary tumor weight, the mitotic tumor cell number, microvessel density, distant tumor metastases and red blood cell immune complexes, while it significantly increased tumor necrosis, thymus cortical thickness, the thymus medullar reticular epithelial cell (REC) number, and the activity of red blood cell C3b receptors. "
4. Mastocytosis
5. Hepatitis

Related Drugs and Biologics

1. Antigen-Antibody Complex (Immune Complex)
2. Interleukin-2 Receptor alpha Subunit
3. Phorbol Esters
4. Complement System Proteins (Complement)
5. Immunoglobulin G (IgG)
6. Complement C3b (C3bi)
7. Fc Receptors (Fc Receptor)
8. Immunoglobulin M (IgM)
9. Immunoglobulin A (IgA)
10. Enzymes

Related Therapies and Procedures

1. Therapeutics
2. Microspheres (Microsphere)
3. Chinese Traditional Medicine (Traditional Chinese Medicine)
4. Drug Therapy (Chemotherapy)